Factors in Cell Membrane Transport and Tissue Distribution of Drugs

药物细胞膜转运和组织分布的因素

基本信息

  • 批准号:
    59460197
  • 负责人:
  • 金额:
    $ 4.99万
  • 依托单位:
  • 依托单位国家:
    日本
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)
  • 财政年份:
    1984
  • 资助国家:
    日本
  • 起止时间:
    1984 至 1986
  • 项目状态:
    已结题

项目摘要

Plasma albumin mediated the uptake of bromosulfophthalein into the isolated rat hepatocytes. The binding behabiour of albumin to hepatocytes revealed non-specific interaction between them, suggesting that there is not an "albumin-receptor" on the hepatocytes. The interaction of albumin with the hepatocyte induced structural changes in both albumin and the cell membrane, which were detected by ESR, difference absorption spectra and fluorescence depolarization. Furthermore, albumin is capable of inceeasing the membeane permeability. This was demonstrated in the permeability of liposomes.The effects of absorption promoters on paracellular and transcellular routes in intestinal membrane were investigated. Promoters enhanced the absorption of water as well as drugs. Ouabain suppressed the drug and water absorption by paracellular promoters such as EDTA, taurocholic acid(TC) and capric acid(C10). The increase in water absorption related to that in absorption site blood flow. For paracellular … More mechanism, C10, C12 and mixed micelles (oleic acid and TC) enlarged the membrane pores in water channel and enavled inulin to permeate through them. For transcellular mechanism, the above promoters interacted with membrane protein and lipid, and caused the membrane perturbation to increase the membrane permeability. Consequently, it was shown that many effective promoters are paracellular ones and also increase the transcellular permeability.fI-protein, a binding protein for acidic substances, was isolated from the cytosol of rat skeletal muscles by Sephadex G-75 (superfine) gel filtration and chromatofocusing. This protein localizes in the interstitial fluid of the muscle and is contained 2.4 mg/g-tissue, determined by fluorescent antibody technique and radial immunodiffussion method, respectively. Ouchterlony double-immunodiffusion indicated that fI-protein was an immunological identity with each fractionated albumin, which was separated by the same procedure as that of fI-protein, fI-protein is like albumin in binding affinity, physicochemical and immunological characteristics. However, the separation profile differs from that of albumin, suggesting that fI-protein originates in the muscle. Less
血浆白蛋白介导溴磺酞进入离体大鼠肝细胞的摄取。白蛋白与肝细胞的结合行为表明它们之间存在非特异性相互作用,提示肝细胞上不存在“白蛋白受体”。白蛋白与肝细胞的相互作用引起白蛋白和细胞膜结构的变化,这是检测ESR,差吸收光谱和荧光去极化。此外,白蛋白还能增加膜的通透性。考察了不同吸收促进剂对脂质体在肠膜中的细胞旁和跨细胞途径的影响。促进剂增强了水和药物的吸收。哇巴因通过细胞旁促进剂如EDTA、牛磺胆酸(TC)和癸酸(C10)抑制药物和水的吸收。水吸收的增加与吸收部位血流量的增加有关。对于细胞旁 ...更多信息 C10、C12及油酸和TC混合胶束扩大了水通道中的膜孔,并促使菊粉通过膜孔。在跨细胞机制中,上述启动子与膜蛋白和脂质相互作用,引起膜扰动,增加膜通透性。因此,许多有效的启动子是旁细胞启动子,也能增加跨细胞渗透性。fI蛋白是一种酸性物质的结合蛋白,通过SephadexG-75(超细)凝胶过滤和层析聚焦从大鼠骨骼肌细胞质中分离得到。该蛋白定位于肌肉的间质液中,用荧光抗体技术和放射免疫扩散法分别测定其含量为2.4mg/g组织。Ouchterlony免疫双扩散试验表明,fI蛋白与各分级分离的白蛋白具有免疫学上的同一性,其结合亲和力、理化性质和免疫学特性与白蛋白相似。然而,分离特征与白蛋白不同,表明fI蛋白起源于肌肉。少

项目成果

期刊论文数量(36)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
水間俊: J.Pharmacobio-Dyn.8. 90-94 (1985)
Shun Mizuma:J.Pharmacobio-Dyn.8。90-94 (1985)
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
梶井寛: J.Pharm.Sci.75. 475-478 (1986)
梶井宏:J.Pharm.Sci.75(1986)。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaharu Shiga: "Promotion of Drug Rectal Absorption Related to Water Absorption" Chem. Pharm. Bull.34. 2254-2256 (1986)
Masaharu Shiga:“促进与吸水相关的药物直肠吸收” Chem。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Masaharu Shiga: "Differences in the Promotion Mechanism of the Colonic Absorption of Antipyrine, Phenol Red and Cefmetazole" J. Pharm Pharmacol.39. 118-123 (1987)
Masaharu Shiga:“安替比林、酚红和头孢美唑结肠吸收促进机制的差异”J. Pharm Pharmacol.39。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
Hiroshi Kajii: "Fluorescence Study on the Interaction of Salicylate with Rat Small Intestinal Epithelial Cells: Possible Mechanism for the Promoting Effects of Salicylate on Drug Absorption In Vivo" Life Sci.37. 523-530 (1985)
Hiroshi Kajii:“水杨酸盐与大鼠小肠上皮细胞相互作用的荧光研究:水杨酸盐促进体内药物吸收作用的可能机制”Life Sci.37。
  • DOI:
  • 发表时间:
  • 期刊:
  • 影响因子:
    0
  • 作者:
  • 通讯作者:
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

AWAZU Shoji其他文献

AWAZU Shoji的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('AWAZU Shoji', 18)}}的其他基金

Improvemrnt of Drug Absorption in Gastro intestinal Tract
改善胃肠道药物吸收
  • 批准号:
    05454573
  • 财政年份:
    1993
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for General Scientific Research (B)

相似海外基金

Diabetes preventive function of cereal albumin considering gendered innovations
考虑性别创新的谷物白蛋白的糖尿病预防功能
  • 批准号:
    23K05099
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of albumin-binding fatty acid-modified nanoparticles for effective cancer therapy
开发用于有效癌症治疗的白蛋白结合脂肪酸修饰纳米颗粒
  • 批准号:
    23K06077
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Development of albumin pre-coating DLC coated artificial vascular graft
白蛋白预涂DLC涂层人工血管的研制
  • 批准号:
    23K08236
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
CAREER: Developing albumin-binding responsive polypeptides for nucleic acid delivery
职业:开发用于核酸递送的白蛋白结合响应性多肽
  • 批准号:
    2238812
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Continuing Grant
ALbumin To Enhance Recovery after severe Acute Kidney Injury (ALTER-AKI): a multicentre randomized controlled trial.
白蛋白促进严重急性肾损伤后的恢复 (ALTER-AKI):一项多中心随机对照试验。
  • 批准号:
    489100
  • 财政年份:
    2023
  • 资助金额:
    $ 4.99万
  • 项目类别:
    Operating Grants
Lymph node-targeted codelivery of albumin-binding peptide antigens and di-adjuvant for melanoma combination immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
  • 批准号:
    10522591
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
Lymph Node-Targeted Codelivery of Albumin-Binding Peptide Antigens and Di-Adjuvant for Melanoma Combination Immunotherapy
用于黑色素瘤联合免疫治疗的白蛋白结合肽抗原和双佐剂的淋巴结靶向共递送
  • 批准号:
    10884052
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
  • 批准号:
    10611521
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
Albumin hitchhiking siRNAs for gene targeting in aged brain
白蛋白搭便车 siRNA 用于老年大脑基因靶向
  • 批准号:
    10467737
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
Albumin-binding nanocomplexes for delivery of combination siRNA therapeutics to KRAS-driven cholangiocarcinoma
白蛋白结合纳米复合物用于向 KRAS 驱动的胆管癌递送组合 siRNA 疗法
  • 批准号:
    10389971
  • 财政年份:
    2022
  • 资助金额:
    $ 4.99万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了